Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...

Pharmaceutical exports from Ireland to the United States could face punitive tariffs "within the next few weeks," according ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Once collaboration was decided upon, the companies gathered to define pharma's biggest issues. "That was an amazing process that we did together," Yerushalmi states. "Each company had a workshop ...

The old Chinese curse that runs ‘may you live in interesting times’ holds today much as it ever did. Two days after Donald Trump announced his new tariff rates (and the international stock market when ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.